Neurodevelopmental disabilities, including autism, attention deficit/hyperactivity disorder, dyslexia, and other cognitive impairment, affect children worldwide. Some diagnoses appear to be increasing in frequency. Industrial chemicals that injure the developing brain are among the known causes. In 2006, we conducted a systematic review and identified five industrial chemicals -lead, methylmercury, polychlorinated biphenyls, arsenic, and toluene -as developmental neurotoxicants.
Introduction
Disorders of neurobehavioural development affect 10-15 % of all births, 1 and prevalence rates of autism spectrum disorder (ASD) and attention deficit/hyperactivity disorder (ADHD), appear to be increasing. 2 Subclinical decrements in brain function are even more common. All of these disabilities can have severe consequences. 3 They diminish quality of life, reduce academic achievement, and disturb behaviours, with profound consequences for the welfare and productivity of entire societies. 4 The root causes of the current global pandemic of neurodevelopmental disorders are only partially understood. Although genetic factors play a role, 5 they cannot explain recent increases in reported prevalence, and none of the genes discovered so far appear to be responsible for more than a few per cent of cases. 5 In the aggregate, genetic factors appear to account for no more than perhaps 30-40% of all cases of neurodevelopmental disorders. Thus, non-genetic, environmental exposures are involved in causation, in some cases likely by interacting with genetically inherited predispositions.
Evidence is strong that industrial chemicals widely disseminated in the environment are important contributors to what we have called the global, silent pandemic of neurodevelopmental toxicity. 6, 7 The developing human brain is exquisitely vulnerable to toxic chemical exposures, and major windows of developmental vulnerability occur in utero and during infancy and early childhood. 8 During these sensitive life stages, exposures can cause permanent brain injury at low levels of exposure that would have little or no adverse effect on an adult.
In 2006, we conducted a systematic review of the published clinical and epidemiological literature on the neurotoxicity of industrial chemicals, with a focus on developmental neurotoxicity. 6 We identified five industrial chemicals that could be reliably classified as developmental neurotoxicants -lead, methylmercury, arsenic, PCBs, and toluene. We also located 201 chemicals that had been reported to cause injury to the nervous system in adults, mostly in connection with occupational exposures, poisoning incidents or suicide attempts. In addition, more than 1000 chemicals have been reported to be neurotoxic in laboratory animals.
We observed that recognition of the risks of industrial chemicals to brain development has historically required decades of research and scrutiny, as illustrated in the cases of lead and methylmercury. 9, 10 Discovery began in most cases with clinical diagnosis of poisoning in workers and episodes of high-dose exposure. More sophisticated epidemiological studies were typically initiated only much later. Results from such studies documented developmental neurotoxicity at much lower levels of exposure that had previously been thought to be safe. Thus, recognition of widespread subclinical toxicity typically did not occur until decades after the initial evidence of neurotoxicity. A recurrent theme was that early warnings of subclinical neurotoxicity were often ignored or even glibly dismissed.
11
Dr. David P. Rall, former Director of the US National Institute of Environmental Health Sciences, once observed that "If thalidomide had caused a ten-point loss of IQ instead of obvious birth defects of the limbs, it would probably still be on the market". 12 Many industrial chemicals currently marketed likely cause IQ deficits much less than 10 points and have therefore so far eluded detection, but their combined effects could have enormous consequences.
In our 2006 review, we expressed concern that additional developmental neurotoxicants might lurk undiscovered among the 201 chemicals then known to be neurotoxic to human adults and among the many thousands of pesticides, solvents, and other industrial chemicals in wide use that had never been tested for neurodevelopmental toxicity. Since our previous review, new data have emerged on the vulnerability of the developing brain and on the neurotoxicity of industrial chemicals. Especially important new evidence derives from prospective epidemiological birth cohort studies.
The present review considers recent information on the developmental neurotoxicity of industrial chemicals and updates our previous report. 6 Additionally, we propose strategies to counter this pandemic and to prevent the spread of neurological disease and disability in children worldwide.
Exquisite vulnerability of the developing brain
The foetus is not well protected against industrial chemicals. The placenta does not block the passage of many environmental toxicants from the maternal to the foetal circulation, 13 and over 200 foreign chemicals have been detected in umbilical cord blood. 14 In addition, many environmental chemicals are transferred to the infant via human milk. 13 During foetal life and early infancy, and the blood-brain barrier provides only partial protection against the entry of chemicals into the central nervous system. 15 Moreover, the developing human brain is uniquely sensitive to injury caused by toxic chemicals, 6 and a number of developmental processes have been shown to be highly vulnerable to chemical toxicity. For example, in vitro studies indicate that neural stem cells are highly sensitive to neurotoxic substances such as methylmercury. 16 Some pesticides inhibit cholinesterase function in the developing brain, 17 thereby affecting the crucial regulatory role of acetylcholine before synaptic formation. 18 Early-life epigenetic changes are also known to affect subsequent gene expression in the brain. 19 In summary, industrial chemicals known or suspected to be neurotoxic to adults are also likely to present risks to the developing brain. 
New findings on known hazards
Recent research on well-documented neurotoxicants has generated important new insights into the neurodevelopmental consequences of early exposures to these industrial chemicals.
Lead. Joint analyses that aggregated data on lead-associated IQ deficits from seven international studies 20, 21 support the conclusion that there is no safe level of exposure to lead. 22 Cognitive deficits in adults, who had previously shown leadassociated developmental delays at school age, suggest that the effects of lead neurotoxicity are probably permanent. 23 Brain imaging of young adults who had elevated blood-lead concentrations during childhood revealed exposure-related decreases in brain volume. 24 Lead exposure in early childhood is associated with decreased school performance 25 and with delinquent behaviour in later life. 26, 27 Methylmercury. Developmental neurotoxicity due to methylmercury occurs at much lower exposures than the levels that affect adult brain function. 28 Deficits at age 7 years that were linked to low-level prenatal exposures to methylmercury were still detectable at age 14. 29 Some common genetic polymorphisms appear to increase the vulnerability of the developing brain to methylmercury toxicity. 30 Functional MRI studies of subjects exposed prenatally to excess levels of methylmercury showed abnormally expanded activation of brain regions in response to sensory stimulation and motor tasks (Figure 2 ). 31 Because some adverse effects may be counterbalanced by essential fatty acids from seafood, statistical adjustment for maternal diet during pregnancy results in stronger methylmercury effects. 32, 33 Arsenic. Prenatal and early postnatal exposures to inorganic arsenic from drinking water are associated with cognitive deficits apparent at school age. 34, 35 Survivors of the Morinaga childhood arsenic poisoning suffer highly elevated risks of neurological disease during adult life. 36 Other known developmental neurotoxicants. The developmental neurotoxicity of PCBs has been consolidated and strengthened by recent findings. 
Newly recognized developmental neurotoxicants
Prospective epidemiologic birth cohort studies make it possible to measure maternal/foetal exposures in real time during pregnancy as these exposures are actually occurring, thus generating unbiased information on the level and timing of prenatal exposures. Children in these prospective studies are followed longitudinally and examined using age-appropriate tests to reveal delayed or deranged neurobehavioural development. These powerful epidemiologic tools have allowed discovery of additional developmental neurotoxicants.
Manganese. Cross-sectional data from Bangladesh show that exposure to manganese from drinking water is associated with decreased mathematics achievement scores in school children. 39 A study in Quebec found a strong correlation between hair-manganese concentrations and hyperactivity. 
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These results are supported by experimental findings in mice. 43 Fluoride. A meta-analysis of 27 cross-sectional studies of children exposed to fluoride in drinking water, mainly from China, suggests an average IQ decrement of about 7 points in children exposed to elevated fluoride concentrations. 44 Confounding from other substances seemed unlikely in most of the studies. Further characterisation of the dose-response relationship would be desirable.
Solvents. The occupational health literature 45 suggests that solvents may act as neurotoxicants, but identification of individual responsible compounds is hampered by the complexity of exposures. A French cohort study of 3,000 children linked maternal occupational solvent exposure during pregnancy to deficits in behavioural assessment at age two years. 46 The data showed dose-related increased risks for attention deficit and aggressive behaviour. One of every five mothers in this cohort reported solvent exposures in common jobs, such as nurse or other hospital employee, chemist, cleaner, hairdresser, and beautician.
In Massachusetts, follow-up of a well-defined population with prenatal and early childhood exposure to the solvent tetrachloroethylene (a.k.a. perchlorethylene) in drinking water showed a tendency toward deficient neurological function and increased risk of psychiatric diagnoses. 47 Pesticides. Acute pesticide poisoning occurs commonly among children worldwide, and subclinical pesticide toxicity is also widespread. Clinical data suggest that acute pesticide poisoning during childhood may lead to lasting neurobehavioral deficits. 48, 49 Highly toxic and bioaccumulative pesticides are banned today in Western nations, but are still used in many low and middle income countries. Especially the organochlorine compounds, dichlorodiphenyltrichloroethane (DDT) and its metabolite dichlorodiphenyldichloroethene (DDE), as well as chlordecone (Kepone), tend to be highly persistent and remain widespread in the environment and in the bodies of people in high-usage regions. Recent studies have documented inverse correlations between serum concentrations of DDT/DDE, which reflect cumulated exposures, and neurodevelopmental performance. 50, 51 Organophosphate pesticides are eliminated from the human body much more rapidly than organochlorines, and exposure assessment is therefore inherently less precise. Nonetheless, three prospective epidemiological birth cohort studies provide new evidence that prenatal exposure to organophosphate pesticides may cause developmental neurotoxicity. In these studies, prenatal organophosphate exposure was assessed by measuring maternal urinary excretion of pesticide metabolites during pregnancy. Dose-related correlations were found between maternal exposures to chlorpyrifos or other organophosphates and small head circumference at birth, a reflection of slowed brain growth in utero, as well as with neurobehavioural deficits that have persisted to at least to age 7. [52] [53] [54] In a subgroup, magnetic resonance imaging of the brain revealed that prenatal chlorpyrifos exposure was associated with structural abnormalities that included thinning of the cerebral cortex. 55 Herbicides and fungicides may also have neurotoxic potential. Experimental evidence now suggests that the PBDEs may also be neurotoxic. 59 Epidemiologic studies in Europe and the US report neurodevelopmental deficits in children with increased prenatal exposures to PBDEs. [60] [61] [62] Thus, the PBDEs should be considered hazards to human neurobehavioural development, although attribution of relative toxic potentials to individual congeners is not yet possible.
Other suspect developmental neurotoxicants
A serious difficulty that complicates many epidemiological studies of neurodevelopmental toxicity in children is the problem of mixed exposures. Most populations are exposed to more than one neurotoxicant at a time, and yet most studies have only limited power and precision in exposure assessment to discern the possible effects of even single neurotoxicants. A further problem in many epidemiological studies of non-persistent toxicants is that imprecise assessment of exposure tends to obscure associations that may, in fact, be present. 63 Guidance from experimental neurotoxicity studies is therefore crucial. In evaluating potential developmental neurotoxicants, we have used a strength of evidence approach similar to that used by the International Agency for Research on Cancer for assessing epidemiological and experimental studies.
Phthalates and Bisphenol A are added to many different types of plastics, cosmetics, and other consumer products. As they are rapidly eliminated in the urine, exposure assessment is complicated, and the imprecision may lead to underestimation of the true risk of neurotoxicity. The best documented effects of early-life exposure to phthalates are the consequence of disruption of endocrine signalling. 64 Thus, prenatal exposures to phthalates have been linked both to neurodevelopmental deficits and behavioural abnormalities characterized by shortened attention span and impaired social interactions. 65 The neurobehavioural toxicity of these compounds appears to be sex-dependent and could therefore relate to endocrine disruption in the developing brain. 66 In regard to Bisphenol A, a prospective study showed that point-estimates of exposure during gestation were linked to abnormalities in behaviour and executive function in the children at age three. 67 Air pollution. Developmental exposures to air pollution can cause neurodevelopmental delays and disorders of behavioural functions. 68, 69 Among individual components of air pollution, carbon monoxide is a well-documented neurotoxicant, and indoor exposure to this substance has now been linked to deficient neurobehavioural performance in children. 70 Less clear is the reported contribution of nitrogen oxides to neurodevelopmental deficits, 71 as these compounds commonly co-occur with carbon monoxide as part of complex emissions. Tobacco smoke is a complex mixture of hundreds of chemical compounds and is now a well-documented cause of developmental neurotoxicity. 72 Infants exposed prenatally to polycyclic aromatic hydrocarbons (PAHs) from traffic exhausts at age 5 years showed greater cognitive impairment and reduced IQ. 68 Perfluorinated compounds, such as perfluorooctanoic acid and perfluorooctane sulfonate, are highly persistent in the environment and in the human body and appear to be neurotoxic. 73 Emerging epidemiological evidence suggests that these compounds may indeed impede neurobehavioural development.
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Developmental neurotoxicity and clinical neurology
Exposures in early life to developmental neurotoxicants are now being linked to specific clinical syndromes in children. Thus, an increased risk of ADHD has been linked to prenatal exposures to manganese, organophosphates, 75 and phthalates. 76 Phthalates have also been linked to behaviours that resemble components of autism spectrum disorder (ASD). 77 Prenatal exposure to automotive air pollution in California has been linked to an increased risk for ASD. 78 The persistent decrements in intelligence documented in children, adolescents, and young adults exposed in early life to neurotoxicants may well presage later development of neurodegenerative disease. Thus, cumulated lead exposure is associated with cognitive decline in the elderly. 79 Manganese exposure may lead to parkinsonism, and experimental studies have reported Parkinson's Disease (PD) as a result of developmental exposures to the insecticide rotenone, the herbicides paraquat and maneb, and the solvent trichloroethylene. 80 Any environmental exposure that increases risk of neurodegenerative disorders in later life ( Figure 1 ) requires urgent investigation as the world population continues to age.
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The expanding universe of neurotoxicants
In our 2006 review, 6 we expressed concern that additional developmental neurotoxicants might lie undiscovered among the 201 chemicals then known to be neurotoxic to human adults, among the approximately 1000 chemicals known to be neurotoxic in animal species, and among the many thousands of industrial chemicals and pesticides that have never been tested for neurotoxicity. Exposure to neurotoxic chemicals is not rare, as almost half of the 201 known human neurotoxicants are considered high-production volume chemicals.
Our updated literature review shows that since 2006 the list of recognized human neurotoxicants has expanded by twelve chemicals from 202 (counting ethanol) to 214 (Table 1 and Appendix table 1 In the same 7-year period, the number of known developmental neurotoxicants has doubled from 6 to 12 (Table 2) . While the pace of scientific discovery of new neurodevelopmental hazards is more rapid today than in the past, it is still slower than the recognition of adult neurotoxicants.
The gap that exists between the number of substances known to be toxic to the adult brain and the smaller number known to be toxic to the much more vulnerable developing brain is not likely to close in the near-term future. This discrepancy reflects the fact that toxicity to the adult brain is usually discovered as a result of acute poisoning incidents, typically with a clear and immediate association between causative exposure and adverse effects, as happens in workplace exposures or suicide attempts. By contrast, the recognition of developmental neurotoxicity relies on two sets of evidence collected at two different points in time -exposure data (often obtained from the mother during pregnancy) and data on the child's postnatal neurobehavioural development (often obtained 5-10 years later). Because brain functions develop sequentially, the full impact of early neurotoxic damage may not become apparent until school age or beyond. The most reliable evidence of developmental neurotoxicity is obtained through prospective studies that include real-time recording of information on exposure in early life followed by serial clinical assessments of the child. Such research is inherently slow and is hampered by inherent difficulty of reliably assessing exposures to individual toxicants in complex mixtures.
Consequences of developmental neurotoxicity
Developmental neurotoxicity causes brain damage that is too often untreatable and frequently permanent. The consequence is impaired central nervous system function that lasts a lifetime and may result in diminished intelligence, as expressed in terms of lost IQ points, or disruption in behaviour. A recent study compared the estimated total IQ losses from major paediatric causes and found that the magnitude of losses due to lead, pesticides and other neurotoxicants to be in the same range or even greater than the losses associated with medical events such as preterm birth, traumatic brain injury, brain tumours and congenital heart disease ( Table 3) . 82 Loss of cognitive skills reduces children's scholarly and economic attainments and has substantial long-term economic impacts on societies. 4 Thus, each loss of one IQ point has been estimated to decrease average lifetime earnings capacity by about €12,000 or $18,000, in 2008 currencies. 83 The most recent estimates from the US indicate that the annual costs of childhood lead poisoning are about US$50 billion and that the annual costs of methylmercury toxicity are approximately US$5 billion. 84 In the EU, methylmercury exposure is estimated to cause a loss of about 600,000 IQ points every year, corresponding to an annual economic loss of close to €10 billion. In France alone, lead exposure is associated with IQ losses that correspond to annual costs that may exceed €20 billion. 85 Given that IQ losses represent only one aspect of developmental neurotoxicity, the total costs must be even greater.
Evidence from worldwide sources indicates that average national average IQ scores are correlated with gross domestic product (GDP), a correlation that may be causal in both directions. 86 Thus, poverty can cause low IQ, but the opposite is also true. Given the widespread exposures to lead, pesticides, and other neurotoxicants in developing countries, where chemical controls may be relatively ineffective compared to those in the more highly developed countries, 87, 88 developmental exposures to industrial chemicals may contribute significantly to the observed correlation between IQ and GDP. If this is true, it may take decades for developing countries to emerge from poverty. As pollution abatement may then be delayed, a vicious circle can result.
The antisocial behaviour, criminal behaviour, violence and substance abuse that appear to result from exposures in early life to some neurotoxic chemicals result in increased needs for special educational services, institutionalization and even incarceration. In the United States, the murder rate fell sharply 20 years after the removal of lead from gasoline, 89 a finding consistent with the notion that exposure to lead in early life is a powerful determinant of behaviour decades later.
Although poorly quantified to date, such behavioural and social consequences of neurodevelopmental toxicity are potentially very costly. 76 Prevention of developmental neurotoxicity caused by industrial chemicals is highly cost-effective. A study that quantified the gains resulting from the phase-out of lead additives from petrol reported that in the US alone, the introduction of leadfree petrol has generated an economic benefit of $200 billion in each annual birth cohort since 1980, 90 an aggregate benefit in the past 30 years of over $3 trillion. This success has subsequently been repeated in more than 150 countries resulting in vast additional savings. Every $1 spent to reduce lead hazards is estimated to produce a benefit of $17 to $220, a cost-benefit ratio even better than that for vaccines. 4 Further, the costs associated with late-life consequences of developmental neurotoxicity are enormous, and the benefits from prevention of degenerative brain disorders may be very substantial.
New methods to identify developmental neurotoxicants
New toxicological methods now allow a rational strategy for identification of developmental neurotoxicants based on a multidisciplinary approach.
91
A new guideline has been approved as a standardised approach to identifying developmental neurotoxicants. 92 However, completion of such tests is expensive and requires the use of large numbers of laboratory animals, and reliance on mammals for chemicals testing purposes needs to be reduced. 93 
US governmental agencies have established the National Center for Computational Toxicology (NCCT)
and an initiative, known as the Tox 21 Program, to promote the evolution of toxicology from a predominantly observational science to a predominantly predictive science. 94 In vitro methods have now reached a level of predictive validity that they can be applied to neurotoxicity testing. 95 Some of these tests are based on neural stem cells. Although these cell systems lack a blood-brain barrier and certain metabolising enzymes, these approaches are highly promising. As a further option, data on protein links and protein-protein interactions can now be used to explore potential neurotoxicity potentials in silico, 96 thus suggesting that existing computational tools may predict potential toxic effects. 97 In summary, using the whole spectrum of approaches along with clinical and epidemiological evidence, when available, should allow for the integration of information for use in at least a tentative risk assessment. Using these tools, we anticipate that the pace of scientific discovery in developmental neurotoxicology will accelerate further in the years ahead.
DISCUSSION
The updated findings presented in this review confirm and extend our 2006 conclusions. 6 During the 7 years since our previous report, the number of industrial chemicals recognized to be developmental neurotoxicants has doubled. Exposures to these industrial chemicals in the environment contribute to the global pandemic of developmental neurotoxicity.
Two major obstacles impede efforts to control the global pandemic of developmental neurotoxicity. These barriers, which we noted in our previous review, 6 and which were recently highlighted by the US National Research Council Classic examples of new chemicals that were introduced because they conveyed certain benefits, but later found to cause great harm include several neurotoxicants as well as asbestos, thalidomide, diethylstilboestrol, and the chlorofluorocarbons. 99 A recurrent theme in each of these instances was that commercial introduction and wide dissemination of the chemicals preceded any systematic effort to assess potential toxicity. Especially absent were advance efforts to examine possible impacts on children's health or potential of exposures in early life to disrupt early development. Similar challenges have been confronted in other public health disasters such as those due to tobacco smoking, alcohol use, and refined foods. These problems have been recently termed industrial epidemics. 100 To control the global pandemic of developmental neurotoxicity, we propose a coordinated international strategy (see Panel). Mandatory and transparent assessment of evidence for neurotoxicity is the foundation of this strategy.
Assessment of toxicity must be followed by governmental regulation and market intervention. Voluntary controls appear to be of little value.
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The three pillars of our proposed strategy are (1) This new agency will assess industrial chemicals for developmental neurotoxicity using a precautionary approach that emphasizes prevention and does not require absolute proof of toxicity. It will facilitate and coordinate epidemiological and toxicological studies, and it will lead the urgently needed global programmes for prevention.
These new approaches must reverse the dangerous presumption that new chemicals and technologies are safe until proven dangerous. These new approaches must overcome the current requirement to produce absolute "proof" of toxicity before initiating action to protect children against neurotoxic substances.
Precautionary interpretation of data on developmental neurotoxicity must take into account the very great individual and societal costs that result from failure to act on available documentation to prevent disease in children. 101 Academic research has often favoured scepticism and required extensive replication before acceptance of a hypothesis, 101 thereby adding to the inertia in toxicology and environmental health research and the resulting disregard of many other potential neurotoxicants. 102 In addition, the strength of evidence that is required to constitute "proof" must be analysed in a societal perspective, so that the implications of ignoring a developmental neurotoxicant and of failing to act on the basis of available data are also taken into account.
Finally, we emphasise that the total number of neurotoxic substances recognized today almost certainly represents an underestimate of the true number of developmental neurotoxicants that have been released into the global environment. Our very great concern is that children worldwide are exposed today to unrecognized toxic chemicals that are silently eroding intelligence, disrupting behaviours, truncating future achievements and damaging societies, perhaps most seriously in developing countries. A new paradigm of action is required.
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